Dr. James Alspaugh, MD

Dr. Alspaugh practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Alspaugh's NPI, 1851440861, was assigned on January 9, 2007. Dr. Alspaugh graduated from Duke University School Of Medicine in 1991. Dr. Alspaugh holds North Carolina license 95-00804.

Dr. Alspaugh's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Alspaugh's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Alspaugh to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alspaugh practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Alspaugh's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Alspaugh is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Alspaugh's licenses on file in 2 states: North Carolina and Tennessee.

Dmand AI lists hiv/aids, urinary tract infection and yeast infection among the conditions Dr. Alspaugh treats.

CMS data shows 166 Medicare services from Dr. Alspaugh across 3 procedure codes in 2024, for 61 Medicare patients. Medicare paid $10,609 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 61 Medicare patients who saw Dr. Alspaugh in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 4.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alspaugh's median patient age at 72, with 49% women.

In 2024, Dr. Alspaugh wrote 659 Medicare Part D claims for 35 patients. CMS names the drug for 551 of them, across 23 drugs with 11 or more claims each, at $1,139,559 in total drug cost. In 2023, CMS named 639 claims across 28 drugs.

Dr. Alspaugh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alspaugh as offering telehealth.

Dmand AI links 58 papers to Dr. Alspaugh, published from 2010 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Cryptococcus neoformans, Fungal Proteins and Cryptococcosis. Dr. Alspaugh has published most often in mBio. Dr. Alspaugh's most frequent co-authors are Manuel Ricardo Amieva, MD, PhD, Bryn A. Boslett, MD and Sharon Fei-Hsien Chen, MD.

CMS Open Payments shows 5 general payments to Dr. Alspaugh from 4 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 93% of the total. Mayne Pharma Inc. paid the most, $1,600.

Dmand AI lists 1 award for Dr. Alspaugh, most recently CMS Stage 1 EHR in 2013.

Dr. Alspaugh graduated from Duke University School Of Medicine in 1991.

Dr. Alspaugh is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.